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The genes required for stem cell specification and lineage restriction during embryogenesis also play funda-
mental roles in adult tissue regeneration and cancer. This ‘‘development-regeneration-cancer’’ axis is exem-
plified by the vertebrate pigmentation system. Melanocytes exhibit almost unlimited self-renewal capacity
during regenerative processes such as mammalian hair recoloration and zebrafish fin regeneration. Mela-
noma utilizes many regulatory signals and pathways required during ontogeny and regeneration. A discus-
sion of these interconnections highlights how studies of stem cell function in embryonic and regenerative
contexts can yield insights into melanoma biology.
The pigmentation of the vertebrate skin has been well studied in
part due to the great variety of mutations that affect diverse spe-
cies from human to zebrafish. Many of these mutations are not
fatal and have allowed for a detailed examination of the involved
genes. These pigment genes have been classically studied in the
context of developmental aberrations, but more recent work has
focused on the remarkable regenerative capacity of the verte-
brate pigmentation unit, including the adult melanocyte. Several
of the genetic requirements of embryonic pigmentation are
strongly shared with the adult regenerative unit. These same
genetic pathways have been demonstrated to be important in
the development of melanoma, a deadly cancer that originates
in the melanocyte. All three of these processes—embryonic de-
velopment, tissue regeneration, and cancer formation—have
a great deal of cellular and genetic events in common. The initial
events involved in embryonic development of the melanocyte lin-
eage depend upon neural crest stem cell specification, followed
by migration/epithelial-mesenchymal transitions, niche localiza-
tion, and maintenance of a balance between multipotency and
differentiation. The adult melanocyte regenerative unit (com-
posed of adult stem cells and progenitor cells) likely becomes
specified during these critical embryonic periods, and the
cellular processes it demonstrates are similar to those of the
embryonic unit. The regenerative unit, however, differs from em-
bryogenesis in the need for unlimited, but tightly regulated, self-
renewal throughout the lifetime of the organism. Many of the
same processes that we have come to associate with the cancer
phenotype, such as self-renewal and migration capacity, are
shared with both the embryonic and regenerative cells. The
purpose of this review is to highlight recent advances in under-
standing these commonalities, using the melanocyte system
as a prototypical example.
Function of Pigmentation
One of the more striking aspects of vertebrate pigmentation is
the interspecies variety of coloration, patterning, and function.
In some species such as birds, pigmentation serves an important
role in identification of mating behaviors (Chaine and Lyon,
2008). In zebrafish, a variety of subspecies, each with different
pigmentation patterns (i.e., Danio rerio with horizontal stripes,
Danio nigrofascitus with vertical stripes, etc.), indicates that
a combination of genetic and environmental cues play a role in
the adult pigment pattern. Pigmentation plays a role not only in
behavioral choices, but strongly protects against ultraviolet light
induced changes in DNA structure, since the skin is almost con-
stantly exposed to high levels of this potential mutagen (Meredith
and Sarna, 2006). Melanin, the principal component of the mela-
nocyte, is one of the most potent free radicals in humans and
helps to protect from the high levels of reactive oxygen species
that would otherwise damage DNA in skin cells.
The Developmental Biology of the Melanocyte
Early Events in Neural Crest Specification
All pigmented melanocytes are derived from a group of migratory
embryonic cells referred to as the neural crest. During gastrula-
tion, the NC is induced at the edge of the neural plate on the bor-
der between the neural and nonneural ectoderm (Erickson and
Reedy, 1998). The derivatives of the neural crest are extensive, in-
dicating that the stem cells which emerge during embryogenesis
are truly multipotent but undergo gradual lineage restriction. The
anatomic location of the crest cell determines, in part, their devel-
opmental potential. Cells in the mid-/hindbrain region form the
cranial neural crest whose derivatives include jaw cartilage and
glia. The vagal and sacral crest gives rise to the neurons of the
enteric nervous syetm. Derivatives such as adrenal cells and
sensory ganglia come from the trunk neural crest. Although pig-
mented melanocytes are typically considered to emerge from
the trunk neural crest, studies in avians have indicated consider-
able developmental plasticity such that cranial neural crest may
give rise to melanocytes as well (Baker et al., 1997).
The early induction of the neural crest is at least in part depen-
dent upon intact BMP signaling, as the BMP2 knockout mouse
shows an almost complete absence of cranial and migratory
neural crest cells (Kanzler et al., 2000). In the chick, BMP4/7 is
induced downstream of Notch signaling, the latter of which is re-
quired for early neural crest development in the zebrafish as well
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(Cornell and Eisen, 2005). The period after induction but before
migration requires the transformation of the neural crest stem
or progenitor cell to undergo an epithelial-to-mesenchymal tran-
sition (EMT) in which downregulation of cell adhesion molecules
such as E-cadherin allow for widespread and stereotyped cellu-
lar movements. One important family of genes involved here are
snail/slug members, which transcriptionally repress E-cadherin
expression and allow for EMT to occur (Cano et al., 2000). Onset
of snail transcription is coincident with migration of neural crest
precursors from the neural plate.
The notch family of proteins play at least 3 distinct roles in neu-
ral crest development. First, it induces cranial neural crest devel-
opment in the frog (Glavic et al., 2004) and chick (Endo et al.,
2003). Second, notch activation plays a crucial role in diversifica-
tion of neural crest progenitors, including the melanocytes. In the
trunk premigratory NC cells, notch signaling prevents receiving
cells from adopting a neuronal fate, instead becoming unspeci-
fied neural crest precursors (Cornell and Eisen, 2002). Support
for a role of notch in the generation of melanocyte precursors is
further supported by the zebrafish mindbomb or whitetail
mutant. This homozygous lethal mutant encodes a defective
E3-ubiquitin ligase that is necessary for adequate cleavage of
the notch ligands on the presenting cell (Itoh et al., 2003). Loss
of this cleavage leads to a deficiency of notch signaling in the
receiving cell. The two names for this mutant adequately reflect
the variety of phenotypes observed, which include a bias toward
a neuronal lineage (thus, mindbomb) but also an almost complete
lack of neural crest derivatives, including crestin-positive premi-
gratory cells and differentiated melanocytes beyond the cranial
region (Kelsh et al., 1996). Whether notch plays a role in prolifer-
ation or survival of these neural crest progenitors is unclear and
awaits further analysis. The third and final important role of notch
signaling is in the maintenance of the adult melanocyte stem cell,
which will be more fully discussed below.
Establishment of theMultipotent Neural Crest StemCell
Multipotent neural crest stem cells (NCSCs) that give rise to
a large number of lineages typical of this cell (Sieber-Blum and
Cohen, 1980) can be isolated flow cytometrically using an anti-
body to p75, and these cells demonstrate self-renewal capacity
(Morrison et al., 1999). Lineage tracing experiments of trunk neu-
ral crest cells supports differentiation into at least four derivatives
(melanocytes, glia, sensory neurons, and adrenal cells) (Bronner-
Fraser and Fraser, 1988). Whether all species have neural crest
stem cells with true multipotency remains unclear, as zebrafish
appear to determine fate restriction prior to overt migration,
but this may be an artifact of the rapid development of the zebra-
fish embryo. The mechanisms by which a NCSC becomes line-
age restricted into the melanocyte fate has been well studied,
and data support the notion that there is a bipotent glial-melano-
cyte lineage progenitor (Dupin et al., 2000), which then becomes
further restricted to an unpigmented, but committed, melano-
cyte lineage cell referred to as the melanoblast. This commit-
ment occurs either within the neural tube or after migration has
commenced. The specific genes involved in each state of mela-
nocyte development from the neural crest, as is understood from
genetic model organisms and human patients, are discussed
below and outlined in Figure 1.
Restricting Neural Crest Stem Cells toward
a Melanoblast Fate
Initial data on the importance of Wnt signaling on neural crest-
derived melanoblasts came from observations of Wnt1;Wnt3a
knockout mice. In the Wnt-deficient animals, almost no melano-
blasts, marked by positivity for dct, were seen (Ikeya et al., 1997).
Studies in the fish have suggested that Wnt signaling, through
activated beta-catenin, promotes a fate decision between mela-
nogenesis and gliogenesis, since overexpression of beta-
catenin leads to an expansion of melanocytes but a loss of glial
derivatives (Dorsky et al., 1998). Using a transgenic approach in
which Wnt1 was activated in a neural precursor line, Pavan
demonstrated that Wnt1 is sufficient for inducing an increase in
melanized (i.e., terminally differentiated) melanocytes, demon-
strating that Wnt1 could influence fate decisions in vivo. Impor-
tantly, beta catenin appears to also expand the population of
neural crest-derived melanoblasts, an effect that is at least partly
Figure 1. Melanocyte Development from the Neural Crest
Early neural crest specification is dependent upon interactions between wnt, notch, and bmp signaling. Slug transcription marks an early specified neural crest
cell and is coincident with migration. Gradual lineage restriction toward the melanoblast fate is dependent upon mitf, EDNRB, and c-kit signaling. The embryonic
melanoblast and adult melanocyte stem cell (MSC) share some overlapping molecular markers, particularly dct. It is unclear if there are some adult MSCs which
arise independently of the embryonic melanoblast.
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dependent upon endothelin-3 (Dunn et al., 2000). Finally, Wnt
signaling is also important for terminal differentiation of melano-
blasts in vitro, and it thus appears that Wnt plays a multifactorial
role in melanocyte lineage decisions.
But in what ways does Wnt/beta-catenin drive the melanocyte
lineage? The most direct evidence comes from observations that
beta-catenin could directly activate the melanocyte-specific mitf
promoter (Takeda et al., 2000). Mitf itself directly interacts with
LEF1, which is part of the transcriptional complex that includes
beta-catenin. Mitf and LEF1 act synergistically to increase tran-
scription of dct (Yasumoto et al., 2002), which sets up a feedback
loop in which mitf is a direct transcriptional target of beta-cate-
nin, and then interacts with the beta-catenin pathway to induce
markers of the restricted melanoblast fate.
Melanocyte Specifiers Drive the Production
of Pigmented Derivatives
The importance of mitf in melanocyte development is widely
seen in both model organisms, such as mice and zebrafish,
but also in human patients with the Waardenburg syndrome
Type IIa (Widlund and Fisher, 2003). The mitf phenotype was ini-
tially identified in a mouse mutant in 1942 (Hertwig, 1942), nota-
ble primarily for its lack of melanocytes rather than a defect in
melanin synthesis. This was really the initial observation that
mitf was required for either specification or survival of the mela-
nocyte lineage in mammals. Mitf encodes a transcription factor
that belongs to the myc family of bHLH-Zip factors (Moore,
1995). Mitf-M, the melanocyte-specific isoform in humans, is
well conserved among vertebrate species, and closely related
genes also appear in the genomes of invertebrates such as
C. elegans (Rehli et al., 1999). In the mouse, 24 alleles of mitf
have been described, which lead to a wide variety of pigmenta-
tion defects, ranging from white coats to spotted coats. The ze-
brafish nacre mutant, which harbors a mutation in themitfa gene,
is completely devoid of both embryonic and adult melanocytes
(Lister et al., 1999). Mitf regulates the melanocyte lineage in
part by acting as a transcriptional activator of several pigment
cell-related genes, including dct, tyrosinase (Yasumoto et al.,
1994), tyrp1 (Yasumoto et al., 1997), c-kit (Tsujimura et al.,
1996), AIM1 (Du and Fisher, 2002), and MC1r (Aoki and Moro,
2002). Fate-mapping studies suggest that mitf is required for me-
lanoblast survival. This occurs prior to migration from the neural
tube (Hornyak et al., 2001), an effect that is in part related to up-
regulation of the bcl2 gene (McGill et al., 2002). Bcl2 and mitf in-
teract to promote the survival of the melanocyte lineage, which
likely explains why mitf mutants have defects in melanocyte
numbers and not generally just defects in melanin synthesis.
Data from humans, mice, and zebrafish have provided a robust
literature regarding the role of c-kit in melanocyte development.
In humans, heterozygous mutations of c-kit lead to the pigmen-
tation disorder referred to as piebaldism (Giebel and Spritz,
1991). Mouse mutants for the c-kit receptor tyrosine kinase
(Geissler et al., 1988) or its ligand, steel/stem cell factor (Williams
et al., 1990), exhibit various degrees of pigmentation defects as
well as hematopoietic and germ cell deficiencies. Kit and the kit-
ligand play a complex role in melanocyte development, survival,
and migration, which appears to depend in part upon the specific
species. Kit mutants never develop the normal number of mela-
nocytes; this may be due to a failure of melanoblast migration in
the mouse (Wehrle-Haller and Weston, 1995) or due to melano-
blast survival in the fish (Parichy et al., 1999). Kit is also required
for mammalian melanoblast differentiation in part due to its co-
operation with mitf signaling (Hemesath et al., 1998; Wu et al.,
2000). Analysis of the zebrafish-sparse mutant, which corre-
sponds to a kit mutation, reveals that embryonic melanocytes
are formed (albeit to a lesser degree than normal) but that these
melanocytes die by 11 days postfertilization, strongly indicating
a role for kit in melanocyte survival. The zebrafish mutant also
supports a role for kit in migration of melanocyte precursors,
since the mutants exhibit a greater proportion of mutant melano-
cytes that are found close to their site of origin than in wild-type
embryos. Finally, the development of the adult pigment pattern
of the zebrafish is abnormal in kit mutants, as they never develop
a population of early adult melanocytes referred to as early stripe
melanocytes. Because these cells are likely derived from a latent
pool of melanocyte stem cells, this data (along with a complete
lack of melanocytes in mouse kit mutants) suggests that kit plays
a role in the development of at least some melanocyte stem cells
in both mice and fish.
The role of the endothelins in neural crest and melanocyte de-
velopment was recognized over a decade ago, when knockout
mice for either the endothelin-B receptor (EDNRB) or its ligand,
endothelin-3 (ET3), were demonstrated to have an almost com-
plete lack of melanocytes (Baynash et al., 1994). In the mouse,
EDNRB is expressed in a subset of premigratory and migrating
neural crest cells and, in vitro, is coexpressed with the melano-
blast marker dct (Pavan and Tilghman, 1994). EDNRB is only re-
quired during a critical period of mouse melanoblast dispersal; its
absence during this period leads to an almost complete loss of
melanocytes in the offspring. (Lee et al., 2003) This would indicate
that the endothelin system is necessary not for initial specification
of a mammalian neural crest-melanocyte lineage but, rather, for
dispersal and survival of the melanoblasts. There appear to be
species-specific functions of the endothelins in pigment pattern
formation, as the zebrafish expresses EDNRB early in develop-
ment in migratory neural crest cells in the dorsolateral and ventro-
medial pathways, but the phenotypic defect of EDNRB mutation
(as seen in the rose mutant fish) does not manifest until the meta-
morphic period, when the adult pigment pattern emerges
(Parichy et al., 2000). This indicates that EDNRB likely plays
a role in neural crest migration in cells destined to become mela-
nocytes in most vertebrates, but that its requirement for differen-
tiation of latent precursors may be species specific. In vitro, ET3
causes a marked expansion of melanocytes from a quail neural
crest culture, due primarily to a large increase in proliferation (La-
hav et al., 1996). ET3 can expand the population of bipotent neu-
ral crest precursors that can give rise to both glial and melano-
cytic lineages, and addition of ET3 can revert differentiated
melanocytes toward a more bipotent state (Lahav et al., 1998).
Melanocyte Regeneration
Given the extensive knowledge of melanocyte development in
the embryo, it is rational to ask whether some of the same
genetic pathways maintain their importance in the adult melano-
cyte system. Along with the hematopoietic system, the adult skin
represents one of the most regenerative organs in vertebrate bi-
ology. On any given day, we generate millions of new epidermal
skin cells as well as hair, both of which are repigmented in an
identical fashion each day by the melanocytes. The coloration
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process of hair and skin differs somewhat, although the princi-
ples are largely the same. In humans, hair typically becomes re-
pigmented due to the transfer of melanin from a differentiated
melanocyte at the base of the hair follicle into the developing
new hair shaft. In the skin itself, melanocytes transfer melanin
to the surrounding keratinocytes, forming the ‘‘pigmentation
unit.’’ In mice, the hair shaft is pigmented in a manner analogous
to humans, but the skin is often (although not invariably) unpig-
mented. Zebrafish, another important model for melanocyte re-
generation, do not have ‘‘hair’’ in this sense, but they offer one
of the most genetically powerful systems for studying melano-
cyte regeneration, which is the fin regeneration model. Although
the epidermal component likely plays an important supportive
role in melanocyte regeneration, this review will focus on the
role of adult melanocyte stem and progenitor cells, since the ker-
atinocyte system has recently been reviewed (Fuchs, 2007). The
incredible longevity of hair pigmentation throughout the adult life
cycle strongly suggested the presence of a cell that would have
the characteristics of a stem cell: slowly cycling, harbored in
a protective niche, and unlimited self-renewal capacity.
Melanocyte Stem Cells in Mammalian Skin
Regeneration of the hair shaft itself, at early anagen, is known to
initiate in the bulge area of the hair follicle, where the keratinocyte
stem cells had been previously localized (Oshima et al., 2001).
Because individual hair follicles must be melanized during each
hair cycle, Nishimura used a dct-lacZ transgenic mouse to follow
the fate of individual melanoblasts during the hair recoloration
cycle (Nishimura et al., 2002). When neonatal mice were treated
with a neutralizing anti-kit antibody, the initial hair cycle of the live
animals were largely unpigmented. However, subsequent hair
cycles showed recoloration of the hair, which demonstrated
that there was a kit-independent population of melanocyte pre-
cursors. This was consistent with the work described above, in-
dicating that although kit is important for survival and migration
of melanocyte precursors and perhaps some stem cells, there
are large numbers of kit-independent melanocytes in the zebra-
fish mutants. When the anti-kit-treated hair was examined, there
was a residual population of kit-independent, dct+ melanoblasts
located in the bulge area of the follicle. Using a combination of
BrdU labeling and transplantation assays, these dct+ melano-
blasts fulfilled all the criteria of a stem cell compartment, includ-
ing very high rates of self-renewal. Because mouse skin is
typically unpigmented in contrast to humans, the authors gener-
ated K14-SLF mice (in which kit ligand or steel factor is
expressed in skin keratinocytes). These animals develop pig-
mented skin similar to humans, and the follicle bulge melanocyte
stem cells appear to migrate toward epidermal niches to allow
for skin pigmentation. Although this does not definitively prove
the location of the human epidermal melanocyte stem cell, it pro-
vides compelling reason to determine whether the hair follicle
bulge may be a common source of all pigment stem cells in
mammals. These data suggest that, much like the hematopoietic
system, there are populations of cells with stem cell/self renewal
capacity as well as those that would be considered ‘‘transient
amplifying’’ compartment when out of the primary niche.
Molecular Profiling of the Mammalian Melanocyte
Stem Cell
It is unlikely that dct alone identifies the melanocyte stem cell,
since it is a marker of virtually all melanocyte lineage cells, sub-
suming both stem cell and differentiated melanocytes. To better
define the nature of the stem cell, Osawa used the dct-Cre/CAG-
CAT-GFP transgenic system, in which all dct+ cells are identified
by GFP positivity (Osawa et al., 2005). After dissecting single hair
follicles from postnatal day 6 skin, two populations of dct+ cells
were isolated—those from the bulb matrix (differentiated mela-
nocytes) or the bulge region (melanocyte stem cells). These
single cells underwent transcriptional profiling using qRT-PCR
to compare the levels of a panel of melanocyte-related genes.
Surprisingly, the postnatal bulge area hair follicles were only pos-
itive for dct and pax3 and virtually negative for the markers tyros-
inase, silver, tyrp1, kit, mitf, sox10, EDNRB, mc1r, oa, and lef1
(the latter by IHC). Some of these markers were also decreased
in embryonic E16.5 melanoblasts (i.e., mc1r, oa, and mitf) but
were positive for ednrb, kit, and sox10. Thus, although the mela-
nocyte stem cells likely arise from the same neural crest-derived
population as the embryonic melanoblast, it is clear that once in
the adult niche, the molecular profile of the stem cell is quite dis-
tinct from that of either embryonic melanoblasts or differentiated
melanocytes in the hair matrix. The precise extent to whichmitf is
expressed in the bulge melanocyte stem cell remains unclear
and warrants further investigation.
The molecular mechanism regulating self-renewal versus dif-
ferentiation of the stem cell remained unknown, but a recent
elegant analysis of the interaction of pax3 with Wnt and mitf pro-
vides some of the answers (Lang et al., 2005). Mitf acts in concert
with sox10 to regulate the dct promoter, but what regulates mitf
activity? Again using the murine hair follicle system, Lang noted
a population of cells within the hair follicle bulge that expressed
Pax3, consistent with the data above. Although Pax3 strongly
upregulates mitf expression itself, it also causes a strong repres-
sion of dct transcription under similar conditions. Mitf, pax3, and
sox10 all bind to an enhancer element in the dct promoter, which
is located nearby to a previously described LEF1-binding site.
Pax3 and mitf thus act as ‘‘competitors’’ on the dct promoter,
and this competition is relieved by beta-catenin binding to the
LEF1 site of the dct promoter. This explains how the Wnt/beta-
catenin pathway regulates the melanocyte lineage, since low
levels of beta-catenin will maintain the stem cell in an undifferen-
tiated state, but upregulation of beta-catenin will then relieve the
pax3-mediated repression of the dct promoter and promote
terminal differentiation into a mature melanocyte.
Notch in Embryonic Melanoblasts and Postnatal
Melanocyte Stem Cells
Nishikawa’s group noted that the E16.5 embryonic melanoblasts
abundantly express several members of the notch family, includ-
ing the notch-1 receptor and the jagged2 ligand, as well as the
notch target genes hes1, hes5, and hey1 (Moriyama et al.,
2006). To address the function of notch in adult melanocytes,
they performed conditional ablation of the RBP-J gene (a medi-
ator of notch signaling in the nucleus) in the melanocyte lineage
using a tyrosinase-Cre driver line. This led to a loss of hair pig-
mentation by the second postnatal hair cycle. However, because
the promoter used in this system was tyrosinase (a differentiated
melanocyte marker), it was difficult to directly ascribe a role for
notch to maintenance of the stem cell itself. Therefore, they ex-
amined notch-related genes in postnatal hair follicles and found
that the bulge melanoblasts (the putative melanocyte stem cell)
were positive for both NICD1 and hes1 and that these were
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downregulated in the differentiated melanocytes in the hair ma-
trix. Further supporting a role for notch in melanocyte stem cell
specification and/or maintenance, compound heterozygous
notch1+/;notch2+/ mice are born with a normal pigment pat-
tern but become increasingly gray starting at the second hair cy-
cle (Kumano et al., 2008). To functionally assess whether notch
was required in the stem cell compartment, the authors then
treated 8-week-old mice with an oral gamma secretase inhibitor
(GSI), which blocks notch activity. These animals began to de-
velop gray spots on their hair at 2 weeks after treatment, and
these defects in hair pigmentation were maintained for at least
6 months after discontinuation of the GSI. Examination of the
bulge region of the hair follicles after GSI using the dct-LacZ sys-
tem revealed a marked decrease in the number of dct+ cells in
the bulge region, supporting at least a supportive if not essential
role for notch signaling in melanocyte stem cell maintenance.
Taken together, these data support a role for the notch pathway
in both embryonic melanoblasts as well as adult melanocyte
stem cells. The precise mechanism by which notch helps to
maintain melanocyte stem cells in a quiescent state and whether
notch directly interacts with pax3, mitf, or dct all await further
characterization.
Mammalian Hair Graying as a Tool for Understanding
Molecular Control of the Melanocyte Stem Cell
The observation that alterations which reduce notch signaling in
the melanocyte stem cell often lead to premature graying high-
lights the utility of hair graying for studying the melanocyte
stem cell. Since hair undergoes essentially constant cycling/re-
pigmentation throughout life, the gradual loss of hair coloration
with age (i.e., ‘‘physiologic aging’’) in both mouse and humans
suggested the possibility that defects in melanocyte stem cells
could play a role. To examine this, Nishimura used two mutant
Figure 2. Examples of Melanocyte
Regeneration
Repigmentation of mammalian hair requires an
intact melanocyte stem cell. In the bcl2/ mouse
(A), hair graying is related to failure to maintain the
melanocyte stem cell in the follicle bulge niche. A
similar mechanism is involved in human hair gray-
ing. In (B), the highly organized repigmentation of
the amputated zebrafish fin is demonstrated.
Whereas little repigmentation is seen in the first
2 days following amputation (left), a progressive
increase in melanocytes are seen over the next 7
days (right) such that the original pigmentation
pattern is fully recapitulated by 2 weeks.
mouse strains that showed evidence of
premature graying, but without affecting
other cell lineages (Nishimura et al.,
2005). The bcl2/mouse is born with es-
sentially normal hair pigmentation, but
the hair grays after the first hair cycle. Ex-
amination of the hair follicles during the
second hair cycle revealed a complete
lack of dct+ melanoblasts in the bulge
area as well as differentiated melano-
cytes in the hair matrix, or bulb, area, as
shown in Figure 2A. This strongly sug-
gests that the melanocyte stem cell is
lost in these animals, since the stem cells are known to exclu-
sively give rise to the differentiated cells in the hair matrix. The
loss of bcl2 in the bulge leads to apoptosis of the stem cell. In
contrast, examination of the mitf vit/vit mouse, which carries
a mild hypomorphic allele of mitf, demonstrates a slower graying
phenotype that correlates with a gradual loss of melanocyte
stem cells from the bulge niche. At early to midanagen of the
third hair cycle, the dct+ cells in the bulge region were seen to
be pigmented and appeared dendritic, both of which are charac-
teristics of premature or ectopic differentiation. In young humans
with colored hair (age 20–30), unpigmented mitf+ cells were seen
in the bulge area, whereas in 40–60 year olds with mild graying,
pigmented mitf + cells were seen in the bulge area, similar to the
mitf vit/vit mice. By age 70–90, the mitf-positive cells were com-
pletely lost. Because pigmented melanocytes should never be
seen in the bulge stem cell niche, the process of hair graying is
likely due to a gradual failure to maintain the melanocyte stem
cell self-renewal in the niche. How mitf might mediate this self-
renewal program is poorly understood, but one mechanism
might relate to its role in cell-cycle entry. Overexpression of
mitf activates p16Ink4a expression, which causes cell-cycle ar-
rest and a morphology consistent with melanocyte differentia-
tion (Loercher et al., 2005). Mitf may also act to promote cell-
cycle arrest through upregulation of p21Cip1, which may act
together with p16Ink4a to promote the effect of mitf on the cell
cycle (Carreira et al., 2005).
A Different Spin on Melanocyte Stem Cells: Fin
Regeneration in the Zebrafish
The regenerative capacity of the teleost fin has been well recog-
nized for decades (for a review, see Poss et al., 2003). In the ze-
brafish, the caudal (tail) fin is the most commonly studied
system, primarily because it is easy to perform a precise
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amputation, and the stages of regeneration in this region can be
precisely well defined. Following initial amputation of the distal
fin, epithelial cells migrate over the wound and cover the surface.
The next stage, essential for normal regrowth, consists of blas-
tema formation, a proliferative mass of mesenchymal cells that
will ultimately form the basis of the new fin structures (Poleo
et al., 2001). It is unclear precisely what these cells are com-
posed of in terms of their multipotency and whether they repre-
sent dedifferentiated cells present in the fin or whether there is
a latent pool of stem cells that then migrate to the blastema. Fol-
lowing blastema formation is the regenerative growth phase,
marked by a much more rapid cell turnover (i.e., the G2 cycle
length shrinks from 6 hr in blastema formation to 1 hr during out-
growth) (Nechiporuk and Keating, 2002). During zebrafish fin
regeneration, the pigment cells completely regrow so that by 1
to 2 weeks postamputation (Figure 2B), the melanocyte pattern
is essentially undistinguishable from normal fins.
The first indication that regenerative pigmentation was derived
from a melanocyte stem cell and not simply migration came from
observations of fin regenerates in the presence of the melanin-
synthesis inhibitor PTU (Rawls and Johnson, 2000). Since PTU
will inhibit melanogenesis only in newly formed melanocytes
(i.e., those that differentiated form an unpigmented precursor),
Rawls amputated fins and allowed them to regenerate in the
presence or absence of PTU. PTU almost completely blocked
visible melanocyte regeneration, but upon removal of the drug,
pigmentation of the regenerate commenced within hours. This
strongly indicated that the cells that form the melanocyte regen-
erate in the fin had previously differentiated from an unpig-
mented, latent precursor. That this precursor cell was likely
a stem cell with unlimited self-renewal was suggested by the
fact that the fin melanocytes would regenerate through at least
10 successive rounds of amputation and regeneration. To get
at the molecular regulation of this potential stem cell, fin regen-
eration was examined in the zebrafish kit mutant (Rawls and
Johnson, 2001). This revealed an almost complete lack of mela-
nocyte regeneration by day 7, and examination of the melano-
blast marker dct in the regenerating fin revealed a complete
lack of expression in the mutant animals. This indicates that kit
is required for at least a subset of regenerating melanocytes in
the fin, but kit mutants eventually do recover the melanocyte pat-
tern in the fin regenerate (Figure 2B), albeit at a much slower rate
than wild-type. This is consistent with the existence of a kit-
independent population of unpigmented melanocyte precursors
in the zebrafish fin, although the molecular identity of these cells
remains obscure.
Small Molecules Reveal Novel Pathways in Melanocyte
Stem/Progenitor Function
One of the major advantages of studying regeneration in the ze-
brafish is the opportunity to perform forward genetic screens.
This allows for unbiased identification of genes that may play
a role in melanocyte regeneration. Recently, Yang et al. used
a clever approach to studying melanocyte regeneration in zebra-
fish larvae (Yang et al., 2007). Previous studies had demon-
strated that the small molecule MoTP could ablate melanocytes
or melanoblasts in the zebrafish larvae and that regeneration of
new melanocytes occurred from proliferation of an undifferenti-
ated precursor (Yang and Johnson, 2006). Taking this as a start-
ing point, Yang performed a parthogenesis (early-pressure) ENU
mutagenesis screen in which they searched for mutants that had
normal ontogenetic melanocyte development during embryo-
genesis but failed to regenerate larval melanocytes after MoTP
treatment. This approach holds significant promise for dissect-
ing the genetic pathways that separate the developmental
requirement of embryonic melanocyte formation from those of
regenerative melanocytes. Two mutants isolated from that
screen, named eartha and julie, encode the gfpt1 (glutamine:-
fructose-6-phosphate aminotransferase 1) and skiv2l2 (super-
killer viralicidic activity 2-like 2) genes, respectively. These two
genes appear to affect different aspects of melanocyte regener-
ation. Gfpt1 mutants develop melanoblasts up to the dct+ stage
but fail to melanize beyond that, suggesting that the gene is re-
quired for the final steps in melanocyte development. In contrast,
the skiv2l2 mutants fail to develop dct+ melanoblasts after MoTP
treatment, suggesting that this gene is necessary for early prolif-
eration of melanocyte precursors prior to the dct+ stage. It is ev-
ident that both of the genetic pathways identified by this screen
will require further investigation in the future to understand their
specific role in melanocyte regeneration beyond the zebrafish.
Developmental Pathways Implicated in Melanoma
Melanoma is the deadliest form of skin cancer (Miller and Mihm,
2006). The incidence of melanoma has been increasing more
rapidly than any other solid tumor, in part likely due to enhanced
detection. There are no particularly effective therapies once the
disease is metastatic, highlighting the need for new approaches
to identifying genetic events that initiate and maintain the tumor.
The past decade has seen a dramatic increase in our knowledge
of melanoma biology, and identification of sentinel events such
as mutations of the B-raf oncogene (Davies et al., 2002) and
loss of the CDKN2A locus (Yang et al., 2005) have been well
documented. For many years, it has been well recognized that
melanomas express a number of markers, discussed above,
that are typical of the embryonic and regenerating melanocyte
lineage (i.e., endothelin and c-kit). However, one challenge in
interpreting this observation has been to understand whether
these markers are simply ‘‘bystanders’’ or whether they serve
specific oncogenic functions. Emerging evidence would suggest
that ‘‘lineage specific’’ markers in melanomas play important
pathological roles, several examples of which will be discussed
below.
Mitf
The concept of ‘‘lineage addiction’’ emphasizes that particular
oncogenic events are specific to the cellular lineage from which
the cancer arises and may only act to promote cancer when in
the correct cellular context. The mitf gene itself is perhaps the
most typical example of this model. Mitf had been known to be
expressed on melanoma cells for several years, although its pre-
cise role in tumorigenesis remained obscure (King et al., 2001).
Garraway et al. used an integrative genomic approach with
high-density SNP arrays to identify areas of copy number gains
or losses in a panel of human melanomas and found that mitf it-
self was amplified in 15%–20% of human melanomas (Garraway
et al., 2005). Mitf demonstrated oncogenic activity, but only in
the presence of aberrant MAP kinase activity induced by B-raf
mutations, suggesting that contextual cues are required for full
oncogenic transformation (i.e., a lineage-specific gene such as
mitf plus a driver mutation such as B-raf). But how does mitf
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act as an oncogene? One potential mechanism involves dysre-
gulation of the cell-cycle arrest that is typically induced by mitf
in melanocytes. This likely involves either p16 (CDKN2A) and/
or Rb. Indeed, loss of p16 (either through deletion of silencing)
is commonly seen in melanomas (Bardeesy et al., 2001), which
suggests one mechanism by which cell-cycle arrest can be
avoided in melanoma cells that express mitf. Beyond its effects
on the cell cycle, mitf exerts broad transcriptional effects on
other genes in the melanocyte lineage such as dct and tyrp1,
as discussed above. Supporting the important function of mitf
as a transcriptional regulator in melanoma, Fisher et al. recently
utilized a ChiP-CHIP approach to understand the promoter
regions where mitf binds in the MALME melanoma cell line and
found that mitf binding sites generally correlate with nucleo-
some-free sites, as expected (Ozsolak et al., 2007). Importantly,
though, the frequency of nucleosome-free promoters was
strongly dependent upon lineage. In melanocytes and mela-
noma cells, expression of both mitf and the melanocyte-lineage
gene SILV correlate, and the SILV promoter is nucleosome-free
in these cell types. In contrast, SILV and mitf are nearly absent in
breast epithelial and breast cancer cells lines, and the SILV
promoter was occupied by a positional nucleosome in these
nonmelanocyte cell lines. Thus, it would appear that regulation
of lineage-specific oncogenes is in part related to the chromatin
accessibility of the promoters in question.
Endothelins
Lahav et al. examined the role of endothelin signaling on mela-
noma growth nearly a decade ago (Lahav et al., 1999). EDNRB
was found to be highly expressed on nearly all melanoma cell
lines tested and appeared to correlate with the differentiation
state of the cell. Treatment of melanoma cells with the specific
EDNRB antagonist BQ788 caused the cells to differentiate and
cease proliferating, in part due to an increase in apoptosis. Inhi-
bition of EDNRB also inhibited tumor growth in a nude mouse
transplant model. The molecular mechanism by which endothe-
lins promote growth of melanoma cells has remained somewhat
obscure, but more recent data indicates that endothelins are
able to transcriptionally upregulate expression of snail, which
allows for downregulation of E-cadherin and upregulation of
N-cadherin, likely contributing to melanoma cell invasiveness
(Bagnato et al., 2004). Perhaps even more strikingly, the endo-
thelins signal through the MAP kinase pathway (Simonson
et al., 1992), providing a significant cooperation with the dysre-
gulated MAPK signaling induced by oncogenic B-raf. Knock-
down of mutant B-raf V600E in melanoma cells (with shRNA)
led to decreased proliferation and reduced colony formation by
80%, an effect that could be partly overcome by addition of en-
dothelin-1 (Christensen and Guldberg, 2005). Finally, the endo-
thelins, particularly ET-1, are known to be hypoxia-responsive
genes, and ET-1 acts to stabilize the HIF1-alpha monomer, lead-
ing to increased production of angiogenic factors such as VEGF
and PGE2 (Spinella et al., 2007). Blockade of EDNRB using the
small molecule A192621 suppresses HIF1a and VEGF-associ-
ated neovascularization in a xenograft model, suggesting that
this pathway is an important mechanism of angiogenesis in mel-
anoma (Grimshaw, 2007). Based in part upon these observation,
a small phase II trial of bosentan (a mixed EDNRA/EDNRB antag-
onist) in advanced melanoma was recently completed, which re-
sulted in ‘‘disease stabilization’’ in 6/32 patients(Kefford et al.,
2007), which is not atypical for small molecule based therapeu-
tics currently in clinical trials.
c-kit
The role of kit in human melanoma has undergone significant
evolution over the past several years. C-kit expression is typi-
cally lost with melanoma progression, suggesting that its loss
is associated with invasion and/or metastasis (Natali et al.,
1992). Nevertheless, several clinical trials have examined the ef-
ficacy of c-kit inhibition, using the multikinase inhibitor imatinib
mesylate, in melanoma. All three of these trials yielded disap-
pointing and essentially negative results (Eton et al., 2004; Ugurel
et al., 2005; Wyman et al., 2006). However, it was recently re-
ported that a significant proportion of melanomas arising from
atypical areas, such as mucosal surfaces, palms, soles, and nail-
beds, harbor activating mutations of the c-kit gene. In one report,
21% of mucosal melanomas had activating kit mutations (Curtin
et al., 2006) and up to 15% of anal melanomas had similar muta-
tions (Antonescu et al., 2007). Most of these mutations occurred
in the juxtamembrane region of the gene, which is known to be
predictive of clinical responses to the kit-inhibitor imatinib mesy-
late. In a preliminary report of a single patient (from a larger phase
II trial) with anal melanoma and a kit mutation, a dramatic re-
sponse to imatinib was seen, with over 50% tumor size reduction
at 4 weeks and an almost complete absence of metabolic activ-
ity seen by FDG-PET (Hodi et al., 2008). This new data indicates
that well-selected patients, with acral or mucosal melanoma and
activating kit mutations, are likely to benefit from this therapy.
Given the paucity of any effective therapy for metastatic mela-
noma, this may represent a significant advance in the treatment
of this subset of patients. The true efficacy of c-kit inhibitors in
melanoma await proper clinical trials using patients selected
for mutation or overexpression.
Notch
Several studies have implicated dysregulated notch signaling in
patients with melanoma. One of the earliest observations by
Hoek et al. was the finding that notch2 and hey1 (a downstream
target) was upregulated by expression microarrays in several
human melanoma cell lines (Hoek et al., 2004). Around the
same time, Qin noted that the gamma-secretase inhibitor
DAPT potently induced apoptosis in 9/9 tested melanoma cell
lines, but not in normal melanocytes, suggesting a particularly
pathogenic function of notch in melanoma (Qin et al., 2004).
Interestingly, the apoptosis was, in part, related to an upregula-
tion of the BH3 family member, NOXA, and was essentially p53
independent. Activation of notch in vertical growth phase
(VGP) melanoma cells, using an activated NICD construct, led
to increases in growth and metastatic potential that was in part
related to activation of the MAP kinase and AKT pathway (Liu
et al., 2006). Consistent with this, a dominant-negative form of
MAML1 (a component of the notch transcriptional complex)
resulted in a decrease proliferation rate in primary, although not
metastatic, melanoma cells, indicating a stage-specific require-
ment for notch signaling (Balint et al., 2005). This pathway has
begun to come under intense scrutiny as a therapeutic target,
with new trials in breast cancer and likely in melanoma in the
near future.
Wnt5a
Although mutations in beta-catenin, the central activator of Wnt
signaling, are seen in melanoma, their frequency is quite low and
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the role of canonical Wnt in melanoma awaits further refinement
(Pollock and Hayward, 2002). In contrast, overexpression of
wnt5a, a member of the ‘‘noncanonical’’ Wnt pathway, may
play an important role in melanoma invasion and metastasis. Us-
ing a hierarchical clustering algorithm, wnt5a defined a subclass
of cutaneous melanoma that exhibited invasive and motile
properties as determined by scratch assay and collagen gels
(Bittner et al., 2000). Wnt5a may mediate this process via induc-
tion of vimentin and snail, factors known to induce the epithelial-
mesenchymal transitions necessary for melanoma metastasis
(Dissanayake et al., 2007).
Slug/Snail
The migratory nature of neural crest derived melanocytes led
Weinberg’s group to question whether these developmental pro-
grams were recapitulated during melanoma metastasis (Gupta,
et al., 2005). Using an identical set of oncogenic insults, including
Ras activation, in three different cell lines, only the transformed
melanocytes gave rise to clinically evident metastasis. This
was due in part to expression of slug, a transcription factor
known to be associated with melanocyte migration during devel-
opment. Whether all cancers have metastatic programs that are
specific to the cell of origin remains an unanswered question,
and awaits further investigation.
dct
Given the central role of dct as a marker of the embryonic mela-
noblast and the melanocyte stem cell, it is reasonable to ques-
tion whether this enzyme plays a pathogenic role in melanoma.
This question has received little attention thus far, but several
studies indicate that this gene may have an important role in
this disease. One of the most interesting observations came
from a study that used a retroviral insertional mutagenesis
screen to isolate melanoma cells that were resistant to the che-
motherapeutic agent cisplatin (Pak et al., 2004). Using gene
expression analysis, the chemoresistant cell line was found to
overexpress dct, and that dct expression correlated well with
chemoresistance in a variety of melanoma cell lines. This corre-
lation seemed to also hold for radiation resistance, as induced by
UV-B. The molecular mechanism of this remains unclear, but one
suggested possibility is that UV-B, which is known to upregulate
dct, activates the ERK/MAPK pathway, which may in part ex-
plain the chemo and radiation resistance of these cells. Dct
may also play a role in progenitor proliferation. Using the
dct-LacZ mouse system, Jiao et al. demonstrated that in the de-
veloping central nervous system, dct+ cells are localized to the
ventricular zone, where neuronal stem cells reside. siRNA medi-
ated knockdown of dct decreases neural progenitor proliferation
Table 1. GenesDemonstrated to Have Important Functions in EmbryonicDevelopment of theMelanocyte Lineage, andCorresponding
Roles in Regeneration and Melanoma
Development Regeneration Cancer
mitf Required for segregation of
multipotent neural crest stem
cells toward a melanocyte fate
in zebrafish and mammals
Expressed in mouse hair follicle
during hair cycling, and lost in
bcl2/-mediated hair graying
(mice, humans)
Amplified and/or overexpressed in
a subset of human melanomas,
represents a lineage specific
oncogene
EDNRB Multiple roles, including early
induction of melanocyte precursors
(mammals, fish) as well as
fate restriction of bipotent
glial-melanocyte toward pigment
fate (mouse, humans)
unknown EDNRB widely expressed on many
human melanomas. Inhibition of this
pathway leads to apoptosis and may
have clinical benefit
C-kit Required for a subset of embryonic
melanocytes in zebrafish, and
differentiation of melanoblasts
in concert with mitf in mice.
Loss leads to human piebaldism
Mutations in kit lead to defects in
melanocyte regeneration in the
zebrafish fin, although there is
kit-independent regeneration.
Expression typically lost with human
melanoma progression. A subset of
mucosal melanomas harbor
activating kit mutations which may
derive clinical benefit from imatinib
slug Early marker of the neural crest
(mouse, fish, Xenopus), required for
epithelial-mesenchymal transition of
migratory neural crest cells
unknown Expression of slug is associated with
metastatic potential of melanoma
(mouse)
dct Central marker of melanoblasts and
melanocyte stem cells (mice), also
directly involved in pigmentation of
the terminally differentiated
melanocyte (mammals, fish)
Expression increases during larval
regeneration in zebrafish and in
regenerating hair follicles of mouse
Expressed in a subset of human
melanomas, but function unclear
notch Notch mutants fail to develop neural
crest in zebrafish. Required for
cranial neural crest induction in frog
and chick
Dominant-negative notch in mouse
melanocyte lineage leads to hair
graying
Inhibition of gamma-secretase leads
to apoptosis of many human
melanoma cells lines. Inhibitors are
in clinical development
wnt Required for early fate decisions
toward a melanocyte fate (mice),
and directly activates the mitf
promoter (mammals and fish)
Inhibition of wnt abrogates entire
zebrafish fin regenerate; specific
effect on melanocytes unclear
Wnt5a overexpressed in a subset of
human melanoma, and associated
with increased invasiveness
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by 48% (Jiao et al., 2006). Although this effect has not yet been
tested in neural crest progenitors and the mechanism remains
obscure, future experiments aimed to elucidate the role of this
melanoblast marker in melanoma seem warranted.
Remaining Questions
It is abundantly clear that human cancers share important char-
acteristics with both development and tissue regeneration (Table
1). This occurs not only at the cellular level, but also on genetic,
genomic, and likely epigenetic bases. One important question
left unanswered by these studies is the relationship of the embry-
onic and adult melanocyte stem cell to the melanoma stem cell.
Recent work by Frank (Schatton et al., 2008) has demonstrated
that the ABCB5 transporter can be utilized to selectively isolate
a subpopulation of melanoma cells that fulfill the criteria of a tu-
mor stem cell, including self-renewal and differentiation capac-
ity. Importantly, a novel anti-ABCB5 antibody could significantly
inhibit tumor growth after transplantation, highlighting the poten-
tial of cancer stem cell based therapeutics in humans with this
disease. What is the overlap between the melanoma stem cell
and normal tissue melanocyte stem cell in terms of signaling
pathways? Several models exist for the generation of a tumor
stem cell: a transformation of an otherwise normal melanocyte
stem/progenitor cell or acquisition of self-renewal capacity in
a more differentiated cell type. In the former case, it is expected
that inhibition of a signaling pathway common to both the tumor
and normal stem cell may have significant antitumor effect but at
the cost of severe inhibition of normal melanocyte regeneration.
This would have significant biological repercussions, since
a continued supply of melanocytes is required for protection
against UV-induced DNA damage. Further molecular char-
acterization of the stem cells present in each period of life—
embryonic, adult, and cancerous—are required to define the dif-
ferences between these cell types and capitalize on these for the
design of rational therapeutic targets in melanoma.
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